“In September 2017 we learned that our son Mohid was suffering from Thalassemia Major”.
He remembers Mohid Ahmad's mother by telling the story of her son's illness.
“He was only three months old at the time. It was unexpected news because my spouse and I are from different cast and ethnic families and had no idea of the disease. We have since started looking for ways to get him to have the bone marrow transplant as blood transfusions and subsequent iron chelation were not a permanent cure. We knew that the risks of living with supportive care (continuous transfusions) in a developing country were greater than the risks associated with a bone marrow transplant. After visiting many BMT units in Pakistan, we learned about the Cure2Children foundation, an Italian ONLUS working in ANTH Islamabad. After visiting the center, we registered our son and started our pre-transplant work. The estimated cost offered by them was much lower than other hospitals offering BMT procedures. Their previous transplant history also showed a 90% success rate. In June 2019 he was hospitalized. Mohid underwent chemotherapy for 18 days. In July 2019 he underwent a bone marrow transplant. His older brother was his 100% compatible donor. A few days after the transplant, Mohid's chimerism was checked and was greater than 95%. That day was a day of immense pleasure for us. By the grace of God, our son is now free from thalassemia and independent of transfusions. Thanks to the Cure2Children foundation and the BMT team of ANTH Islamabad for their support and care ”.
